Reaction
Rhodococcus Infection reporting signals
As of the last recalculation, Rhodococcus Infection appears in 165 FAERS reports alongside 9 co-occurring drug terms. The strongest observed disproportionality signal is TACROLIMUS OINTMENT 0.1% (PRR 298.5).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Tacrolimus Ointment 0.1% | 106 | 298.5 | 298.7 |
| Tacrolimus Extended-Release Capsules | 106 | 297.7 | 297.9 |
| Basiliximab | 23 | 286.5 | 287.1 |
| Tacrolimus | 108 | 249.9 | 250.1 |
| Moxifloxacin | 15 | 147.7 | 147.8 |
| Rifampicin | 11 | 146.9 | 147.0 |
| Mycophenilic Acid | 21 | 146.3 | 146.5 |
| Mycophenolic Acid | 27 | 127.0 | 127.1 |
| Axicabtagene Ciloleucel | 4 | 52.4 | 52.4 |